Next-Generation cDNA Screening for Oncogene and Resistance Phenotypes

Nobuaki Shindoh; Akinori Yoda; Yuka Yoda; Timothy J. Sullivan; Oliver Weigert; Andrew A. Lane; Nadja Kopp; Liat Bird; Scott J. Rodig; Edward A. Fox; David M. Weinstock

doi:10.1371/journal.pone.0049201

Loading metrics

Open Access

Peer-reviewed

Research Article

Next-Generation cDNA Screening for Oncogene and Resistance Phenotypes

Nobuaki Shindoh ,

Contributed equally to this work with: Nobuaki Shindoh, Akinori Yoda, Yuka Yoda

Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Drug Discovery Research, Astellas Pharma Inc., Tsukuba, Ibaraki, Japan
⨯
Akinori Yoda ,

Contributed equally to this work with: Nobuaki Shindoh, Akinori Yoda, Yuka Yoda

Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Yuka Yoda ,

Contributed equally to this work with: Nobuaki Shindoh, Akinori Yoda, Yuka Yoda

Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Timothy J. Sullivan,

Affiliation Microarray Core, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Oliver Weigert,

Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Andrew A. Lane,

Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Nadja Kopp,

Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Liat Bird,

Affiliation Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America
⨯
Scott J. Rodig,

Affiliations Harvard Medical School, Boston, Massachusetts, United States of America, Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America
⨯
Edward A. Fox,

Affiliations Microarray Core, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America
⨯
David M. Weinstock

* E-mail: dweinstock@partners.org

Affiliations Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America
⨯

Next-Generation cDNA Screening for Oncogene and Resistance Phenotypes

Nobuaki Shindoh,
Akinori Yoda,
Yuka Yoda,
Timothy J. Sullivan,
Oliver Weigert,
Andrew A. Lane,
Nadja Kopp,
Liat Bird,
Scott J. Rodig,
Edward A. Fox

Published: November 7, 2012
https://doi.org/10.1371/journal.pone.0049201

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

DNA libraries
Is the Subject Area "DNA libraries" applicable to this article?

Thanks for your feedback.
Cloning
Is the Subject Area "Cloning" applicable to this article?

Thanks for your feedback.
cDNA library screening
Is the Subject Area "cDNA library screening" applicable to this article?

Thanks for your feedback.
Library screening
Is the Subject Area "Library screening" applicable to this article?

Thanks for your feedback.
Polymerase chain reaction
Is the Subject Area "Polymerase chain reaction" applicable to this article?

Thanks for your feedback.
Exon mapping
Is the Subject Area "Exon mapping" applicable to this article?

Thanks for your feedback.
cDNA libraries
Is the Subject Area "cDNA libraries" applicable to this article?

Thanks for your feedback.
Next-generation sequencing
Is the Subject Area "Next-generation sequencing" applicable to this article?

Thanks for your feedback.